Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
James R. Eckman, MD
Healthcare Provider Professor Emeritus
Department of Hematology
and Medical Oncology
Emory University School of Medicine
100 Woodruff Circle
Atlanta, Georgia, United States
James Eckman, MD, is emeritus professor of the Department of Hematology and Medical Oncology and held appointments as professor of medicine and adjunct professor of pediatrics in medical genetics at Emory University School of Medicine. He was committed to establishing a sickle cell program at Grady Memorial Hospital, and after intensive state lobbying for funding in 1984, became medical director of the world’s first 24-hour comprehensive acute care sickle cell center.
Dr. Eckman’s other interest is in public health services for individuals with genetic diseases. He has championed newborn screening for sickle cell disease on a local and national level. His work has saved the lives of many sickle cell children who would have died from pneumococcal sepsis if timely preventive care with oral penicillin prophylaxis was not started. He serves as a member of several local and national committees and acts as an advocate to continue awareness and support of these programs.
Dr. Eckman has broad research experience in basic science, translational research, clinical research and clinical trials. These have included studies of red cell metabolism; sickle erythrocyte endothelial interactions; coagulation activation with sickle complications; psychological and social complications from sickle cell disease; drug and chemotherapy of sickle complications; pain assessment and management; and bone marrow transplantation in sickle disease.
+myBinderRelated Content
-
Acute Care Utilization Is More Common in Patients with Sickle Cell Disease Who Have Chronic Complications and Chroni...Background: We undertook a large multisi...
-
Mark C. Walters, MDDr. Walters is the director of Bone Marr...
-
Sensorineural Hearing Loss in Children With Sickle Cell DiseaseIntroduction: Sensorineural hearing los...
-
GBT launches ACCEL grants program to improve access to care for people with Sickle cell diseaseGlobal Blood Therapeutics, Inc. (GBT) to...
-
David Beidler, PhDAs the Translational Sciences lead for t...
-
University Hospitals Seidman Cancer CenterUniversity Hospitals Seidman Cancer Cent...
-
2019 Annual Sickle Cell Symposium – Sickle Cell: Past Present and FutureDRAFT Agenda 5:00pm Registration, netwo...
